Table 3.
Comparison between patients aged ≤37 years (group 1) and patients aged >37 years (group 2). For all variables—positive values. EBV: Epstein-Barr virus; VZV: varicella zoster virus; CMV: cytomegalovirus; TBC: tuberculosis (Mantoux skin test or QuantiFERON-TB Gold).
| Group 1 (≤37 years) | Group 2 (>37 years) | p value (total, group 1 versus group 2) | |||||
|---|---|---|---|---|---|---|---|
| Total (% +ve) | CD (% +ve) | UC (% +ve) | Total (% +ve) | CD (% +ve) | UC (% +ve) | ||
| VCA-IgG EBV | 114/134 (85.1%) | 68/82 (82.9%) | 46/52 (88.5%) | 190/202 (94.1%) | 99/107 (92.5%) | 91/95 (95.8%) | p = 0.006 |
| VZV-IgG | 87/104 (83.7%) | 48/59 (81.4%) | 39/45 (86.7%) | 144/152 (94.7%) | 80/85 (94.1%) | 64/67 (95.5%) | p = 0.003 |
| CMV-IgG | 66/129 (51.2%) | 37/78 (47.4%) | 29/51 (56.9%) | 152/199 (76.4%) | 79/104 (76%) | 73/95 (76.8%) | p < 0.0001 |
| TBC | 0/126 (0%) | 0/80 (0%) | 0/46 (0%) | 21/189 (11.1%) | 15/112 (13.4%) | 6/77 (7.8%) | p < 0.0001 |